The Schmidt Chest Clinic brings together nationally recognized pulmonary specialists, cutting edge technology, and exciting research to provide the highest quality pulmonary care available. Below is a list of our research that we are participating in.


Air Quality and COPD Quality Improvement

Dr. Denitza Blagev is currently the Medical Director of Quality, Specialty care for Intermountain Healthcare and the Director of the Lung Cancer Screening Program. Her research interests include optimization of care in COPD and emphysema, telehealth and remote patient monitoring as well as air pollution. Learn more about the Air Quality Study

Chronic Thromboembolic Pulmonary Hypertension

Dr. Mark Dodson focuses on understanding the genetic basis of chronic thromboembolic pulmonary hypertension (CTEPH), and developing predictive models that could help doctors identify patients at risk of developing CTEPH at the time of an acute pulmonary embolism. 
Internal Medicine-man-with-Woman-pt

Critical Care Echocardiography

Dr. Michael Lanspa's principal area of research is the application of ultrasound in the ICU, with an emphasis on heart-lung interactions and fluid assessment. He has authored independent research and book chapters on this subject and has taught ultrasound nationally and internationally. Additionally, he has published in the areas of glucose control in the critically ill and aspiration pneumonia. He chairs both the American Society of Echocardiography's point-of-care-ultrasound track and the American Thoracic Society's ultrasound course, and is on the Society of Critical Care Medicine's Glycemic Control Guideline Task Force. Read about Dr. Michael Lanspa's scientific publications

Critical Care Survivorship

Dr. Sarah Beesley explores the patient and family experience in the intensive care unit. Learn more about the Center for Humanizing Critical Care.
A nurse in blue scrubs holding papers in her hand talks with a male patient in a clinic waiting room

Genetics of Interstitial Lung Disease

Dr. Peter Crossno is the Director of the Schmidt Chest Clinic and runs the Interstitial Lung Disease clinic. He collaborates with the University of Utah Lung Research Center in working towards discovery of genes associated with the development and progression of interstitial lung disease. Current Intermountain Research and Medical Foundation funded efforts include work with the Intermountain Biorepository and the Utah Population Database to identify genes within families affected by pulmonary fibrosis and interstitial lung diseases. Learn more about the research grants that aim to improve patient care and reduce costs.


Dr. Nathan Dean is the Chief of the Pulmonary Division at Intermountain Medical Center. He has served three times on the national pneumonia treatment guideline committees of the infectious Disease Society of America and American Thoracic Society, and has written more than 50 papers regarding community-acquired pneumonia. Current research focuses on electronic clinical decision support for ED physicians to improve care of pneumonia patients. 

Pulmonary Hypertension

Dr. Gregory Elliott and his team focuses upon the genetics and genomics of Pulmonary Hypertension, including the discovery of genes that cause inherited Pulmonary Hypertension and characterizing the phenotypes that these genes cause. These discoveries hold the promise of finding new medications which reverse the basic causes of Pulmonary Hypertension. 

Pulmonary Physiology

Dr. Matthew Hegewald is the Director of the Pulmonary Function Laboratory. He and his research team explore the effects of altitude on cardiopulmonary exercise and pulmonary function testing. He is actively engaged in Quality Improvement and Quality Control in pulmonary function testing.